Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Reuters_Health Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::25562183.png) Reuters Health [@Reuters_Health](/creator/twitter/Reuters_Health) on x 253.8K followers
Created: 2025-07-26 05:15:08 UTC

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive impairment.

![](https://pbs.twimg.com/card_img/1948955851437248512/662Nh9dN?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948975349615775900/c:line.svg)

**Related Topics**
[atai life](/topic/atai-life)
[stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries)

[Post Link](https://x.com/Reuters_Health/status/1948975349615775900)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Reuters_Health Avatar Reuters Health @Reuters_Health on x 253.8K followers Created: 2025-07-26 05:15:08 UTC

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive impairment.

XXX engagements

Engagements Line Chart

Related Topics atai life stocks bitcoin treasuries

Post Link

post/tweet::1948975349615775900
/post/tweet::1948975349615775900